Want to see AU:AHE full AI Analyst Report?
AHE Stock Chart & Stats
AU$0.01
AU$0.00(0.00%)
―
--
Day’s Range― - ―
52-Week RangeAU$0.01 - AU$0.03
Previous CloseN/A
VolumeN/A
Average Volume (3M)331.21K
Market Cap
AU$8.93M
Enterprise Value-AU$1.74M
Total Cash (Recent Filing)AU$9.53M
Total Debt (Recent Filing)AU$131.74K
Price to Earnings (P/E)―
Beta1.42
Next Earnings
Mar 04, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding637,981,000
10 Day Avg. Volume430,074
30 Day Avg. Volume331,209
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)-3.12
Price to Sales (P/S)0.22
P/FCF Ratio-0.74
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)<0.01
Revenue Forecast (FY)AU$112.30M
Bulls Say, Bears Say
Bulls Say
Integrated Healthcare Technology PlatformThe company serves multiple participants in the medication ecosystem through one healthcare technology platform. Its pharmacy workflow, medication-management, and consumer engagement tools provide a broad operating base that can support recurring relationships and diversified healthcare program opportunities over time.
Debt ReductionMaterial debt reduction by 2026 is a constructive balance-sheet development because it can lower financing pressure and improve flexibility relative to the prior year. Although negative equity remains a major constraint, reduced debt provides a modest foundation for stabilisation if operating performance improves.
Prior Cash-flow CapacityPositive operating and free cash flow in 2024 demonstrates that the business has previously generated cash internally rather than relying exclusively on external funding. The improvement was not sustained, but this historical capacity could become relevant if revenue quality and operating discipline recover.
Bears Say
Negative Shareholder EquityNegative shareholder equity materially weakens the balance sheet and limits financial flexibility. It also increases perceived solvency risk because the recorded asset base does not provide a positive equity buffer against continued losses, making recovery more dependent on improved operations or additional funding.
Persistent Cash BurnSustained operating and free-cash-flow deficits indicate that the core business is consuming cash rather than funding itself. Continued burn can restrict investment in products and services, increase dependence on financing, and leave less resilience if losses persist through the next several quarters.
Weak And Volatile EarningsDeclining revenue combined with negative gross profit, very large operating losses, and substantial net losses shows that the platform is not currently converting activity into sustainable earnings. This weak and volatile earnings base undermines internal funding capacity and makes future performance highly dependent on a successful operating recovery.
MedAdvisor Limited News
AHE FAQ
What was MedAdvisor Limited’s price range in the past 12 months?
MedAdvisor Limited lowest share price was AU$0.01 and its highest was AU$0.03 in the past 12 months.
What is MedAdvisor Limited’s market cap?
MedAdvisor Limited’s market cap is AU$8.93M.
When is MedAdvisor Limited’s upcoming earnings report date?
MedAdvisor Limited’s upcoming earnings report date is Mar 04, 2027 which is in 124 days.
How were MedAdvisor Limited’s earnings last quarter?
MedAdvisor Limited released its earnings results on Aug 30, 2026. The company reported -AU$0.043 earnings per share for the quarter.
Is MedAdvisor Limited overvalued?
According to Wall Street analysts MedAdvisor Limited’s price is currently Undervalued.
Does MedAdvisor Limited pay dividends?
MedAdvisor Limited does not currently pay dividends.
What is MedAdvisor Limited’s EPS estimate?
MedAdvisor Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does MedAdvisor Limited have?
MedAdvisor Limited has 637,981,000 shares outstanding.
What happened to MedAdvisor Limited’s price movement after its last earnings report?
MedAdvisor Limited reported an EPS of -AU$0.043 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of MedAdvisor Limited?
Currently, no hedge funds are holding shares in AU:AHE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
MedAdvisor Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:AHE Sentiment 100%
Sector Average 64%
Sector Average 64%
Insider Transactions
Bought Shares
Worth AU$78.1K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-51.72%
12-Months-Change
Fundamentals
Return on Equity
-614.15%
Trailing 12-Months
Asset Growth
-58.36%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
MedAdvisor Limited
Adheris Health Limited, together with its subsidiaries, provides pharmacy-driven patient engagement solutions in Australia, the United States, and the United Kingdom. The company offers THRiV, an omni-channel platform which provides pharmacy-driven patient and pharmacist engagement solutions to improve medication management. The company was formerly known as MedAdvisor Limited and changed its anme to Adheris Health Limited in November 2025. The company was incorporated in 2010 and is based in Woburn, Massachusetts.
Technical Analysis
Oneview Healthcare Chess Depository Interests repr 1
―
PharmX Technologies
―
Alcidion Group Limited
―
InteliCare Holdings Limited
―
PainChek Ltd
―